Serum Antibodies against CD28– A New Potential Marker of Dismal Prognosis in Melanoma Patients

Rebecca Körner; Klaus-Dieter Preuss; Natalie Fadle; Darius Madjidi; Frank Neumann; Lennart Bergeler; Stefan Gräber; Cornelia S. L. Müller; Frank Grünhage; Michael Pfreundschuh; Frank Lammert; Thomas Vogt; Claudia Pföhler

doi:10.1371/journal.pone.0058087

Loading metrics

Open Access

Peer-reviewed

Research Article

Serum Antibodies against CD28– A New Potential Marker of Dismal Prognosis in Melanoma Patients

Rebecca Körner ,

Contributed equally to this work with: Rebecca Körner, Klaus-Dieter Preuss

* E-mail: rebecca.koerner@uks.eu

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯
Klaus-Dieter Preuss ,

Contributed equally to this work with: Rebecca Körner, Klaus-Dieter Preuss

Affiliation Department of Internal Medicine I and José Carreras Centre for Immuno and Gene Therapy, Saarland University Hospital, Homburg/Saar, Germany
⨯
Natalie Fadle,

Affiliation Department of Internal Medicine I and José Carreras Centre for Immuno and Gene Therapy, Saarland University Hospital, Homburg/Saar, Germany
⨯
Darius Madjidi,

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯
Frank Neumann,

Affiliation Department of Internal Medicine I and José Carreras Centre for Immuno and Gene Therapy, Saarland University Hospital, Homburg/Saar, Germany
⨯
Lennart Bergeler,

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯
Stefan Gräber,

Affiliation Institute for Medical Biometry, Epidemiology and Medical Informatics, Saarland University Hospital, Homburg/Saar, Germany
⨯
Cornelia S. L. Müller,

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯
Frank Grünhage,

Affiliation Department of Internal Medicine II, Saarland University Hospital, Homburg/Saar, Germany
⨯
Michael Pfreundschuh,

Affiliation Department of Internal Medicine I and José Carreras Centre for Immuno and Gene Therapy, Saarland University Hospital, Homburg/Saar, Germany
⨯
Frank Lammert,

Affiliation Department of Internal Medicine II, Saarland University Hospital, Homburg/Saar, Germany
⨯
Thomas Vogt,

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯
Claudia Pföhler

Affiliation Department of Dermatology, Saarland University Hospital, Homburg/Saar, Germany
⨯

Serum Antibodies against CD28– A New Potential Marker of Dismal Prognosis in Melanoma Patients

Rebecca Körner,
Klaus-Dieter Preuss,
Natalie Fadle,
Darius Madjidi,
Frank Neumann,
Lennart Bergeler,
Stefan Gräber,
Cornelia S. L. Müller,
Frank Grünhage,
Michael Pfreundschuh

Published: March 6, 2013
https://doi.org/10.1371/journal.pone.0058087

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Autoantibodies
Is the Subject Area "Autoantibodies" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
CD coreceptors
Is the Subject Area "CD coreceptors" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.
Recombinant proteins
Is the Subject Area "Recombinant proteins" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.